Arcus Biosciences and Roche company Genentech are partnering on two clinical trials for colorectal and pancreatic cancer.

The U.S. FDA approved Kyowa Kirin’s Nourianz (istradefylline) as an add-on treatment to levodopa/carbidopa in adults with Parkinson’s disease who experience “off” episodes.

Novartis has broadened its immuno-oncology pipeline with the acquisition of Admune Therapeutics and through licensing agreements with small drug developers Xoma and Palobiofarma.   Palobiofarma, a Spanish biotech company, said separately it entered into a $15 million licensing agreement with the Swiss group. Novartis said in a statement on Wednesday these transactions add Admune’s IL-15 […]

LONDON – AstraZeneca will release preclinical data from more than 50 medicines in an effort to find new cancer treatments as part of a new challenge to tap the minds of researchers and clinicians across the globe. AstraZeneca’s decision is part of a crowd-sourcing effort to accelerate the development for “synergistic tumor-fighting drug combinations,” Reuters […]